| Name | Title | Contact Details |
|---|---|---|
John Kelly |
Chief Information Officer | Profile |
Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe. It develops AT-001, a prostaglandin E receptor 4 antagonist to treat the pain and inflammation associated with osteoarthritis in dogs, as well as for the management of pain in cats; AT-002, a potent and selective ghrelin agonist for the stimulation of appetite in cats and dogs; and AT-003, a bupivacaine liposome injectable suspension to manage post-operative pain in cats and dogs following surgery. The company was founded in 2010 and is headquartered in Kansas City, Kansas.
Kaiser Permanente is a physician-led medical group in Northern and Central California that provides quality medical care to over 3.8 million members. They practice a multi-lingual, culturally inclusive approach to care that celebrates the diversity of ...
LifeScript is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Action Ambulance has been a leader in EMS in Eastern Massachusetts for over 25 years. Action provides 24-hour emergency and non-emergency pre-hospital medical care and transportation to ill or injured individuals. We are available to over a million
Peloton Advantage is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.